Back

Extracellular vesicles in hypertrophic cardiomyopathy patients

29 August 2026 (12:40 - 12:50)
Organised by: Logo
Congress Presentation Part of: New insights into hypertrophic cardiomyopathy Hypertrophic Cardiomyopathy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Massimiliano Ruscica

IRCCS Ca Granda Foundation - Milan Polyclinic Maggiore Hospital, Milan (Italy)

4 More presentations in this session

Presentation thumbnail
Mavacamten versus septal reduction therapy in obstructive hypertrophic cardiomyopathy: a propensity score-matched analysis from a global real-world network
Ms Y. Srivastava (IN)
Abstract Slides
Presentation thumbnail
Cardiac Myosin inhibitor improves mid-ventricular obstruction in hypertrophic cardiomyopathy
Doctor L. Lina (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Gene-specific reclassification patterns of variants in hypertrophic cardiomyopathy
Doctor A. Bakalakos (London, GB)
Abstract
Presentation thumbnail
Family screening outcomes in gene-elusive HCM
Doctor P. Martin Marin (London, GB)
Abstract

Access the full session

Session thumbnail
New insights into hypertrophic cardiomyopathy
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 12:40 CET
You may be interested in
thumbnail
Congress Presentation
Comprehensive proteomics profiling reveals molecular pathways that are differentially regulated in hypertrophic cardiomyopathy and correlate with clinical markers of disease severity
27 August 2021
thumbnail
Congress Presentation
Characterization of extracellular vesicles from patients with severe aortic stenosis undergoing transcatheter aortic valve implantation and assessment of their coagulation potential
13 April 2024
thumbnail
Congress Presentation
External validation study of the 2014 European Society of Cardiology Guidelines in relation to 2020 ACC/AHA guidelines on sudden cardiac death prevention in hypertrophic cardiomyopathy
3 April 2022
thumbnail
Congress Presentation
Extracellular vesicles derived from hyaluronic acid primed induced pluripotent stem cell derived mesenchymal stem cell can ameliorate the heart function.
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources